Merck's (NASDAQ: $MRK) $680M Harpoon Therapeutics Acquisition Further Diversifies Oncology Pipeline

https://ift.tt/IhpJV2k

https://ift.tt/G5rDdX8 Submitted January 09, 2024 at 02:08AM by ExternalCollection92 https://ift.tt/hbup1AN